Johnson & Johnson (JNJ) just secured back-to-back FDA approvals for two therapies, representing a meaningful expansion in ...
Paramount shares jumped more than 10% Tuesday after the company’s third-quarter earnings report and a strategy update from ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果